Financial Incentives for Smoking Cessation

(Aniqsaaq-RCT Trial)

Recruiting in Palo Alto (17 mi)

Overseen by Christi A Patten, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Mayo Clinic

Must not be taking: Pharmacotherapy

Disqualifiers: Marijuana, Prior study, others

No Placebo Group

Trial Summary

What is the purpose of this trial?

The current study will conduct an RCT to evaluate the effectiveness of a family-based incentive intervention with Alaska Native/American Indian families. The experimental arm will be compared to a control arm on biochemically-confirmed smoking abstinence at 6- and 12-months post-intervention.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it does exclude those who have used stop smoking medications in the past 3 months.

What data supports the effectiveness of the treatment Family-Based Financial Incentives Intervention for smoking cessation?

Research shows that financial incentives, such as monetary rewards or vouchers, can help people quit smoking by encouraging and sustaining behavior change. These incentives have been used successfully in various settings, including workplaces and hospitals, to increase smoking cessation rates.

^{1 2 3 4 5}

Is the use of financial incentives for smoking cessation safe for humans?

The research articles reviewed do not provide specific safety data regarding the use of financial incentives for smoking cessation, but they focus on the effectiveness and feasibility of these interventions.

^{2 6 7 8 9}

How is the Family-Based Financial Incentives Intervention for smoking cessation different from other treatments?

This treatment is unique because it uses financial rewards to encourage people to quit smoking, which is different from traditional methods like nicotine replacement or counseling. It involves family members, making it a more supportive and community-focused approach.

^{2 3 4 6 9}

Eligibility Criteria

This trial is for Alaska Native/American Indian families looking to quit smoking. Participants must meet certain criteria, but specific inclusion and exclusion details are not provided.

Inclusion Criteria

Index Participant: Willing to complete and sign an Internal Revenue Service (IRS) W-9 tax identification form if they wish to receive payments on the study

Index Participant: Self-report smoking in the past 7 days, biochemically verified with saliva cotinine ≥ 30 ng/mL

Index Participant: Have or will nominate one adult family member to enroll with them

Exclusion Criteria

I have used medication or a program to quit smoking in the last 3 months.

Index Participant: Already enrolled in the study with another family member

Index Participant: Participated in a prior study phase

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a family-based incentive intervention for smoking cessation, with smoking status check-ins weekly for four weeks, then at three and six months

6 months

6 visits (in-person or virtual)

Follow-up

Participants are monitored for smoking abstinence at 12 months post-intervention

6 months

Participant Groups

The study tests if offering financial rewards helps families stop smoking. It's a randomized controlled trial comparing this approach with a control group, checking results at 6 and 12 months after the intervention.

Group I: Rewards Group Experimental Treatment 1 Intervention

Index participants in the Rewards Group will be scheduled to complete smoking status check-ins six times during the 6-month Treatment Phase: weekly for four weeks, then at three and six months. At each check-in, cigarette smoking abstinence will be assessed. Participants in the Rewards Group will receive informational materials on smoking cessation.

Group II: Comparison Group Active Control 1 Intervention

Index participants in the Comparison Group will be scheduled to complete smoking status check-ins six times during the 6-month Treatment Phase: weekly for four weeks, then at three and six months. At each check-in, cigarette smoking abstinence will be assessed. Participants in the Comparison Group will receive informational materials on smoking cessation.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Alaska Native Tribal Health Consortium Anchorage, AK

Who Is Running the Clinical Trial?

Mayo Clinic Lead Sponsor

National Institute on Drug Abuse (NIDA) Collaborator

Alaska Native Tribal Health Consortium Collaborator

References

1. Netherlands pubmed.ncbi.nlm.nih.gov

Incentives and Patches for Medicaid Smokers: An RCT. [2019] Most successful trials of financial incentives for smoking cessation have offered large rewards contingent on outcomes. This study examines whether more modest incentives to encourage engagement, non-contingent on outcomes, also increase cessation; whether sending medications directly to participants boosts quitting; and whether these strategies are effective in Medicaid.

2. England pubmed.ncbi.nlm.nih.gov

Goal-directed versus outcome-based financial incentives for smoking cessation among low-income, hospitalised patients: rationale and design of the Financial Incentives for Smoking Treatment II (FIESTA II) randomised controlled trial. [2023] Smoking remains the leading preventable cause of death in the USA. Low utilisation of treatments for smoking cessation remains a major barrier for reducing smoking rates. Financial incentives represent an innovative approach to increasing use of therapies for smoking cessation. This paper will describe the rationale and design of the Financial Incentives for Smoking Treatment II (FIESTA II) study, a randomised controlled trial to evaluate the effectiveness and feasibility of goal-directed and outcome-based financial incentives to promote smoking cessation among hospitalised smokers.

3. England pubmed.ncbi.nlm.nih.gov

Effectiveness of providing financial incentives to healthcare professionals for smoking cessation activities: systematic review. [2018] Financial incentives are seen as one approach to encourage more systematic use of smoking cessation interventions by healthcare professionals. A systematic review was conducted to examine the evidence for this.

4. England pubmed.ncbi.nlm.nih.gov

Incentives for smoking cessation. [2023] Financial incentives, monetary or vouchers, are widely used in an attempt to precipitate, reinforce and sustain behaviour change, including smoking cessation. They have been used in workplaces, in clinics and hospitals, and within community programmes.

5. England pubmed.ncbi.nlm.nih.gov

Effect of a workplace-based group training programme combined with financial incentives on smoking cessation: a cluster-randomised controlled trial. [2019] Financial incentives are potentially useful tools to aid smoking cessation, but robust evidence to support their efficacy, particularly in combination with other interventions (eg, group counselling), has not been reported. We aimed to investigate whether financial incentives combined with a smoking cessation group training programme (compared with a training programme with no incentives) organised at the workplace would increase 12-month abstinence rates in tobacco-smoking employees with different education and income levels.

6. England pubmed.ncbi.nlm.nih.gov

Perceptions of Financial Incentives for Smoking Cessation: A Survey of Smokers in a Country With an Endgame Goal. [2019] Financial incentives can support smoking cessation, yet low acceptability may limit the wider implementation of such schemes. Few studies have examined how smokers view financial-incentive interventions aimed at reducing smoking prevalence.

7. England pubmed.ncbi.nlm.nih.gov

Financial incentives for smoking cessation in pregnancy: a single-arm intervention study assessing cessation and gaming. [2022] Financial incentives were the single most effective intervention for smoking cessation in pregnancy in a recent Cochrane Review, but based on a few small trials in the United States using only 7-day point prevalence measures of cessation. This study estimates (a) prolonged cessation in an unselected population of English pregnant smokers who are offered financial incentives for quitting and (b) 'gaming', i.e. false reporting of smoking status to enter the scheme or gain an incentive.

8. England pubmed.ncbi.nlm.nih.gov

Going Once, Going Twice: Using Willingness-to-Accept Auctions to Promote Smoking Cessation. [2021] Incentive-based smoking cessation interventions increase quit rates. The optimal incentive, however, is unknown. We used a willingness-to-accept (WTA) auction where smokers submitted bids indicating the incentive they would need to receive for 1 week of smoking cessation.

9. United States pubmed.ncbi.nlm.nih.gov

The use of financial incentives in promoting smoking cessation. [2022] Cigarette smoking is the leading cause of preventable death in the United States and world. Despite the availability of numerous therapies for smoking cessation, additional efficacious interventions are greatly needed. We provide a narrative review of published studies evaluating financial incentives for smoking cessation and discuss the parameters important for ensuring the efficacy of incentive interventions for smoking cessation.